Stockreport

Why The Narrative Around Kura Oncology Is Shifting After Komzifti's FDA Breakthrough [Yahoo! Finance]

Kura Oncology, Inc.  (KURA) 
Last kura oncology, inc. earnings: 2/25 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.kuraoncology.com/investor-relations
PDF Kura Oncology's narrative is shifting as analysts lift their fair value estimate from $31.8 to $33.0 per share while nudging the discount rate slightly higher to about 7 [Read more]